EC Number | Cloned (Comment) | Organism |
---|---|---|
3.1.1.4 | into pET28a(+) vector, transformation of Escherichia coli strain BL21 | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.1.4 | 3-(3-acetamido-2-benzyl-2-ethylindolyl-5-oxy)propane phosphonic acid | LY311727, IC50 value of 36 nM, group IIa and V sPLA2 | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.1.1.4 | secretory granule | - |
Homo sapiens | 30141 | - |
3.1.1.4 | secretory granule | - |
Rattus norvegicus | 30141 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.1.1.4 | Ca2+ | - |
Mus musculus | |
3.1.1.4 | Ca2+ | - |
Homo sapiens | |
3.1.1.4 | Ca2+ | - |
Rattus norvegicus |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.1.1.4 | 16000 | - |
SDS-PAGE | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.4 | phospholipids + H2O | Homo sapiens | influence on platelet aggregation | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | Rattus norvegicus | influence on platelet aggregation | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | Homo sapiens | signal transduction | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | Mus musculus | eicosanoids | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | Homo sapiens | eicosanoids | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | Rattus norvegicus | eicosanoids | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | Homo sapiens | inflammatory diseases | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | Rattus norvegicus | inflammatory diseases | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.1.4 | Homo sapiens | - |
- |
- |
3.1.1.4 | Mus musculus | - |
- |
- |
3.1.1.4 | Rattus norvegicus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.1.1.4 | Ni-NTA affinity chromatography | Homo sapiens |
EC Number | Renatured (Comment) | Organism |
---|---|---|
3.1.1.4 | - |
Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.1.4 | heart | - |
Homo sapiens | - |
3.1.1.4 | leukocyte | peripheral blood | Homo sapiens | - |
3.1.1.4 | liver | - |
Homo sapiens | - |
3.1.1.4 | liver | - |
Rattus norvegicus | - |
3.1.1.4 | lung | - |
Homo sapiens | - |
3.1.1.4 | lung | - |
Rattus norvegicus | - |
3.1.1.4 | placenta | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.1.1.4 | 0.5 | - |
substrate: 1-palmitoyl-2-arachidonylphosphatidylcholine | Homo sapiens |
3.1.1.4 | 1.8 | - |
substrate: 1-palmitoyl-2-linoleoylphosphatidylcholine | Homo sapiens |
3.1.1.4 | 3.22 | - |
substrate: 1,2-dipalmitoyl-phosphatidylcholine | Homo sapiens |
EC Number | Storage Stability | Organism |
---|---|---|
3.1.1.4 | -4°C, for months without losing enzymatic activity | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.4 | 1,2-dipalmitoyl-phosphatidylcholine + H2O | - |
Homo sapiens | 1-palmitoyl-glycerophosphorylcholine + palmitic acid | - |
? | |
3.1.1.4 | 1,2-dipalmitoyl-phosphatidylcholine + H2O | - |
Rattus norvegicus | 1-palmitoyl-glycerophosphorylcholine + palmitic acid | - |
? | |
3.1.1.4 | 1-palmitoyl-2-arachidonoylphosphatidylcholine + H2O | - |
Homo sapiens | 1-palmitoyl-glycerophosphorylcholine + arachidonic acid | - |
? | |
3.1.1.4 | 1-palmitoyl-2-arachidonoylphosphatidylcholine + H2O | - |
Rattus norvegicus | 1-palmitoyl-glycerophosphorylcholine + arachidonic acid | - |
? | |
3.1.1.4 | 1-palmitoyl-2-linoleoylphosphatidylcholine + H2O | - |
Rattus norvegicus | 1-palmitoyl-glycerophosphorylcholine + linolic acid | - |
? | |
3.1.1.4 | 1-palmitoyl-2-linoleoylphosphatidylcholine + H2O | group V sPLA2 | Homo sapiens | 1-palmitoyl-glycerophosphorylcholine + linolic acid | - |
? | |
3.1.1.4 | 1-palmitoyl-2-linoleoylphosphatidylethanolamine + H2O | - |
Homo sapiens | 1-palmitoyl-glycerophosphorylethanolamine + linolic acid | - |
? | |
3.1.1.4 | 1-palmitoyl-2-linoleoylphosphatidylethanolamine + H2O | - |
Rattus norvegicus | 1-palmitoyl-glycerophosphorylethanolamine + linolic acid | - |
? | |
3.1.1.4 | phospholipids + H2O | influence on platelet aggregation | Homo sapiens | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | influence on platelet aggregation | Rattus norvegicus | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | signal transduction | Homo sapiens | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | eicosanoids | Mus musculus | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | eicosanoids | Homo sapiens | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | eicosanoids | Rattus norvegicus | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | inflammatory diseases | Homo sapiens | ? | - |
? | |
3.1.1.4 | phospholipids + H2O | inflammatory diseases | Rattus norvegicus | ? | - |
? |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.1.1.4 | 8.5 | - |
- |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.1.1.4 | 0.000036 | - |
LY311727, IC50 value of 36 nM, group IIa and V sPLA2 | Homo sapiens | 3-(3-acetamido-2-benzyl-2-ethylindolyl-5-oxy)propane phosphonic acid |